ArticleBMC urology2026
Surgical complications, functional outcomes and associated factors among men underwent transurethral resection of the prostate at Benjamin Mkapa Hospital, Tanzania.
Article in BMC urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTransurethral resection of the prostate (TURP) is the gold standard surgical treatment for moderate to severe lower urinary tract symptoms due to benign prostatic hyperplasia. However, data on surgical complications and functional adverse outcomes in Tanzania remain limited. This study assessed the incidence and factors associated with surgical complications and described functional adverse outcomes following TURP at Benjamin Mkapa Hospital (BMH).
methodsA retrospective cohort study was conducted using routinely collected data from men aged ≥ 40 years who underwent TURP at BMH between 2021 and 2023 with at least one year of follow-up. Patients with prior prostate or urethral surgery, neurogenic bladder, or incidental prostate cancer were excluded. Logistic regression was used to estimate crude and adjusted odds ratios (ORs) with 95% confidence intervals (CIs).
resultsAmong 705 men (mean age 69 ± 8.9 years), 67 (9.50%) developed surgical complications, and 76 (10.78%) had functional adverse outcomes. Overall, 132 (18.72%) had at least one recorded outcome, noting that the two categories were not mutually exclusive and functional adverse outcomes may include pre-existing conditions due to a lack of baseline assessment. Ejaculatory dysfunction (10.35%) was the most common functional adverse outcome, while urethral stricture (4.54%) was the most frequent surgical complication. Late complications (6.80%) were more common than early complications (2.98%). Hypertension (aOR = 2.06, 95% CI: 1.20-3.53) and diabetes (aOR = 4.81, 95% CI: 2.36-9.80) were independently associated with higher odds of surgical complications, while prostate size < 80 cm³ was protective (aOR = 0.58, 95% CI: 0.33-0.93).
conclusionSurgical complication rates following TURP at BMH were comparable to international reports. Hypertension, diabetes, and larger prostate size were associated with higher odds of surgical complications. Functional adverse outcomes were common but should be interpreted cautiously because baseline functional status was not systematically assessed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.